Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04586049 · ClinicalTrials.gov registry record
Cardiovascular and Neurovascular Regulation in GWI
A clinical trial of Neurovascular Control and Brain Blood Flow, sponsored by University of Wisconsin, Madison.
- Active
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT04586049: Active study of Neurovascular Control and Brain Blood Flow, sponsored by University of Wisconsin, Madison.
NCT04586049 is a study of Neurovascular Control and Brain Blood Flow that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04586049, a study of Neurovascular Control and Brain Blood Flow, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.
- ACTIVE NOT RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Brain blood flow regulation and autonomic dysfunction will be measured in Veterans with and without Gulf War Illness who served in the Gulf War between 1990 and 1992.
Primary Outcome
Neurovascular control will be investigated by measuring the change in brain blood flow using a transcranial Doppler ultrasound in response to a breathing test.
Conditions Studied
Interventions
- DEVICE MRI
- DEVICE Transcranial Doppler Ultrasound
- OTHER Sympathetic Nerve Activity
Study Locations (1)
Wisconsin
- University of Wisconsin-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-05-16 |
| Est. Completion | 2026-06 |
What the registry record for NCT04586049 still lists
NCT04586049 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 2 conditions, with Neurovascular Control appearing as the primary indexed condition, and to 3 interventions - of which MRI is the first listed.
NCT04586049 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04586049 about?
NCT04586049 is a clinical study titled "Cardiovascular and Neurovascular Regulation in GWI". Brain blood flow regulation and autonomic dysfunction will be measured in Veterans with and without Gulf War Illness who served in the Gulf War between 1990 and 1992.
What is the current status of trial NCT04586049?
This trial is currently active not recruiting. The enrollment target is 70 participants. The study started on 2023-05-16. Estimated completion is 2026-06.
What conditions does trial NCT04586049 study?
This clinical trial studies the following conditions: Neurovascular Control, Brain Blood Flow.
What interventions are being tested in trial NCT04586049?
The interventions under investigation include: MRI (DEVICE), Transcranial Doppler Ultrasound (DEVICE), Sympathetic Nerve Activity (OTHER).
Who is sponsoring clinical trial NCT04586049?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04586049 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurovascular Control
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI